Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Layton

Showing results (341-350 of 360) with videos related to

Pageof 36
Sort By:
JAAD International|June 5, 2023
The Personalized Acne Treatment Tool - Recommendations to facilitate a patient-centered approach to acne management from the Personalizing Acne: Consensus of ExpertsAlison M Layton, Andrew Alexis, Hilary Baldwin, et al.
Plos Neglected Tropical Diseases|August 29, 2024
Development of a Core Outcome Measure Instrument; "LeishCOM_LCL", for Localised Cutaneous LeishmaniasisShalindra Ranasinghe, Sujai Senarathne, Vijani Somaratne, et al.
Nature Communications|January 12, 2021
Characterization of a new Leishmania major strain for use in a controlled human infection modelHelen Ashwin, Jovana Sadlova, Barbora Vojtkova, et al.
BMJ Open|December 11, 2023
Cost-effectiveness of Spironolactone for Adult Female Acne (SAFA): economic evaluation alongside a randomised controlled trialSarah Pyne, Tracey H Sach, Megan Lawrence, et al.
Trials|August 27, 2025
Social media recruitment enhances participant diversity in dermatology clinical trial: findings from the SAFA trialCherish Boxall, Susanne Renz, Beth Stuart, et al.
JAMA|March 7, 2001
Botulinum toxin as a biological weapon: medical and public health managementS S Arnon, R Schechter, T V Inglesby, et al.
Advances in Experimental Medicine and Biology|December 19, 2007
Mutation of the von Hippel-Lindau gene alters human cardiopulmonary physiologyT G Smith, J T Brooks, G M Balanos, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 30, 2021
Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in SudanBrima M Younis, Mohamed Osman, Eltahir A G Khalil, et al.
JAMA|June 21, 2001
Tularemia as a biological weapon: medical and public health managementD T Dennis, T V Inglesby, D A Henderson, et al.
Emerging Infectious Diseases|October 5, 2001
Widespread West Nile virus activity, eastern United States, 2000A A Marfin, L R Petersen, M Eidson, et al.
Pageof 36

Showing results (341-350 of 360) with videos related to

Sort By:
Pageof 36
JAAD International|June 5, 2023
The Personalized Acne Treatment Tool - Recommendations to facilitate a patient-centered approach to acne management from the Personalizing Acne: Consensus of ExpertsAlison M Layton, Andrew Alexis, Hilary Baldwin, et al.
Plos Neglected Tropical Diseases|August 29, 2024
Development of a Core Outcome Measure Instrument; "LeishCOM_LCL", for Localised Cutaneous LeishmaniasisShalindra Ranasinghe, Sujai Senarathne, Vijani Somaratne, et al.
Nature Communications|January 12, 2021
Characterization of a new Leishmania major strain for use in a controlled human infection modelHelen Ashwin, Jovana Sadlova, Barbora Vojtkova, et al.
BMJ Open|December 11, 2023
Cost-effectiveness of Spironolactone for Adult Female Acne (SAFA): economic evaluation alongside a randomised controlled trialSarah Pyne, Tracey H Sach, Megan Lawrence, et al.
Trials|August 27, 2025
Social media recruitment enhances participant diversity in dermatology clinical trial: findings from the SAFA trialCherish Boxall, Susanne Renz, Beth Stuart, et al.
JAMA|March 7, 2001
Botulinum toxin as a biological weapon: medical and public health managementS S Arnon, R Schechter, T V Inglesby, et al.
Advances in Experimental Medicine and Biology|December 19, 2007
Mutation of the von Hippel-Lindau gene alters human cardiopulmonary physiologyT G Smith, J T Brooks, G M Balanos, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 30, 2021
Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in SudanBrima M Younis, Mohamed Osman, Eltahir A G Khalil, et al.
JAMA|June 21, 2001
Tularemia as a biological weapon: medical and public health managementD T Dennis, T V Inglesby, D A Henderson, et al.
Emerging Infectious Diseases|October 5, 2001
Widespread West Nile virus activity, eastern United States, 2000A A Marfin, L R Petersen, M Eidson, et al.
Pageof 36